Objective: To describe the methodology of transurethral seminal vesiculoscopy and the anatomy of the seminal tract, and to report a single-surgeon experience with this procedure. Methods: A total of 38 consecutive patients with intractable macroscopic hemospermia were enrolled from January 2010 to July 2016. A 6/7.5-Fr semirigid ureteroscope was used to enter the seminal tract by one of these two approaches: through either a trans-ejaculatory duct opening or a trans-utricle fenestration. Patient characteristics and their preoperative and postoperative measurements were analyzed retrospectively. Results: The success rate of transurethral seminal vesiculoscopy was 92.1%, whereas the approaching method in most patients was the trans-utricle fenestration (88.89%). A total of 34 (94.4%) transurethral seminal vesiculoscopy inspections ended with complete remission, even though nearly half of them (47.2%) only disclosed negative perioperative findings. The median period to complete remission was 4 weeks (interquartile range 4-6 weeks) after the procedure. Four patients had recurrent hemospermia, and the median time to recurrence was 21.5 (range 13-48.5) months. Conclusions: Transurethral seminal vesiculoscopy is a valuable diagnostic tool for intractable hemospermia, and also plays a therapeutic role by blocking the vicious cycle of stasis, calculi and seminal vesiculitis. More familiarity of the anatomy and enough practice would make the learning curve less steep.
Introduction
Hemospermia might be a primary symptom of some serious diseases involving the male seminal tract, including infection, inflammation, ductal obstruction, neoplasm, trauma, iatrogenic injury and some systemic diseases, such as severe hypertension or hematological diseases. 1 However, hemospermia is usually a benign and self-limiting disease. Amano et al. reported that 57% of hemospermia patients have symptom remission 1 month after the initial episode. 2 The relative benign nature of hemospermia raises the diagnostic dilemma regarding the optimal timing for investigation and specifically which population of patients requires simple reassurance instead of an invasive procedure for evaluation.
Current imaging examinations used for the differential diagnosis of hemospermia include the TRUS, pelvic computed tomography and MRI. However, all these examinations play only diagnostic roles and might result in a false negative if there are small lesions. TUSV, in contrast, provides a direct visual examination for the interior of the seminal tract and also a therapeutic benefit concurrently. Xing et al. even reported that TUSV offers a higher diagnostic yield than TRUS (74.5% vs 45.3%, P < 0.001). 3 However, TUSV is indeed a challenging procedure for surgeons who are just starting to use the procedure. We intend to show the anatomy of the seminal tract and describe the methodology of the TUSV approach using a 6/7.5-Fr ureteroscope. Although the surgical technique was similar to previous studies, the present study aimed to offer more comprehensive anatomy with cross-section illustrations and to make the learning curve of this procedure less steep.
Methods Patients
All patients presented to the urology clinic at Taichung Veterans General Hospital, Taiwan, for macroscopic hemospermia from January 2010 to July 2016 were enrolled, and only patients who were diagnosed with intractable hemospermia were studied. Intractable hemospermia is defined as a persistent hemospermia with duration exceeding 3 months regardless of medical treatments (including antibiotics with or without non-steroidal anti-inflammatory medication). The enrolled patients went through preoperative physical examinations, urinalyses, serum PSA and coagulation tests, as well as transrectal ultrasonography. The empiric antibiotic regimen is ciprofloxacin 400 mg every 12 h for a minimum of 2 weeks.
The exclusion criteria included proved or highly suspect lower urinary tract malignancy, poorly controlled hypertension, cirrhosis or deteriorated liver function, anticoagulant therapy (but patients taking antiplatelets agents were not excluded due to relatively weak potency) and acute urinary tract infections. Patients with known hematological malignancy were also excluded.
The study protocol conformed to the ethical guidelines of the 1975 Declaration of Helsinki and was approved by the ethics committee of Taichung Veterans General Hospital, Taichung, Taiwan. The institutional review board number was CE17218A.
Surgical techniques
Each patient was to receive spinal or general anesthesia, and was placed in the lithotomy position. A semirigid ureteroscope (6/7.5-Fr; Olympus, Tokyo, Japan) was introduced transurethrally to the verumontanum. The anatomy of the distal seminal tract and its surroundings are shown in Figure 1 .
There were two methods for applying the transurethral seminal vesiculoscope.
Through the ejaculatory duct
The first method is the approach through an opening of bilateral ejaculatory ducts located at the bottom of the verumontanum (Fig. 2) . The seminal vesicles and the opening of the vas deferens can be examined subsequently. The opening of the ejaculatory duct might be covered with thin membranous tissue, which would hinder the entry of the ureteroscope. In such situations, we used the second method to access.
Trans-utricle fenestration
The second method is to make a fenestration through the prostate utricle (Fig. 3) . The ureteroscope would be inserted into the utricle orifice first. The junctions between the prostate utricle and the seminal vesicles are typically located on the lateroposterior aspect of the utricle wall. These junctions consist of thin soft tissues and appear to be covered with a blue translucent membrane. The trick for identifying the junction is to use pulsatile low-pressure saline irrigation, and then monitor the induced movements of the utricle wall. Specifically, the membranous junction often appeared in a periodic motion of sinking and bulging as driven by the pulsatile flow. A 0.038-inch Zebra guidewire was used for puncturing through the thin membrane and the ureteroscope would then be introduced into the seminal vesicles.
Sometimes, the fenestration method might fail in those patients with thick membranous junction due to a longer separation in the distance between the seminal vesicle and prostate utricle. In these cases, we would arrange MRI instead of TUSV for the differential diagnosis of hemospermia.
Seminal vesicle fluid would be collected for bacterial culture. Stone removal with an endoscopic instrument or biopsy of suspicious mucosal lesions would be carried out if indicated. After the inspection of internal structures, 10 mL of saline solution with 80 mg of gentamycin would be used to rinse each seminal vesicle. An 18-Fr Foley catheter would be placed to drain the urine overnight.
The patients came back for the first outpatient follow up 1 week after the procedure, and then received regular follow up every 3 months. Complete remission was based on the statements of the patients after at least three ejaculations.
Statistical analysis
Numerical variables are presented as the median (interquartile range). The diagnostic proportion was studied with the McNemar test, and statistical significance was set at P < 0.05. Statistical analysis was carried out using MedCalc version 17.8.6 (MedCalc Software bvba, Ostend, Belgium).
Results
A total of 99 patients presented to our urology department for gross hemospermia between 2010 and 2016. Just 38 patients diagnosed with intractable hemospermia were studied. The characteristics are shown in Table 1 . TUSV was carried out successfully in 35 patients (92.1% of 38 patients).
A total of 34 (94.44%) TUSV inspections (on 33 patients) resulted in complete remission. One of the two patients with persistent hemospermia showed negative TUSV findings, and the other had stones in the utricle and left seminal vesicle complicated with pseudomonas infection in bilateral seminal vesical cultures. Both patients had partial alleviation of hemospermia.
Of 33 patients (consisting of 34 investigative episodes) with complete remission, four (same number of investigative episodes) had recurrent hemospermia. Three patients reported the disappearance of hemospermia after treatment with ciprofloxacin for 2 weeks, whereas the remaining patient received a second TUSV as a result of being refractory to medical therapy. This patient was a 68-year-old man with hemospermia diagnosed 5 years earlier. He had complete remission 1 month after the first seminal vesiculoscopy. Utricle stones were found and removed. His hemospermia recurred 8 months later, and recurrent utricle stones were identified in the second TUSV. Hemospermia disappeared after the second TUSV with no recurrence during the following 22-month period.
Just two of 16 cases of seminal tract stones removal had enough volume for chemical analysis. One was a pure calcium phosphate stone, and the other was a mixed magnesium ammonium phosphate and calcium phosphate stone (Fig. 4) . Other perioperative and postoperative outcomes are shown in Table 2 .
All three patients received MRI after failed TUSV. One patient had a seminal vesical cyst (had been seen in TRUS), whereas the other two patients had tiny prostate cysts (only one had been diagnosed in TRUS). We maintained conservative treatment and followed up. All three patients had improved hemospermia after 1 year, but two of them had the recurrence at 9 and 13 months after remission.
Discussion
TUSV is a challenging procedure for surgeons just beginning to use the procedure. The illustration of the surgical method in the present study would be helpful for building 3-D anatomy and achieving familiarity with the seminal tract. The present results also suggest that TUSV could be used as either a diagnostic tool or a therapeutic intervention for intractable hemospermia. The possible mechanism is to block the vicious cycle of stasis, calculi and seminal vesiculitis regardless of the surgical findings.
TRUS is the most widely used tool to examine hemospermia because of its convenience and non-radiation exposure characteristics. TRUS provides real-time images with good resolution and is more affordable to patients. Yagci et al. concluded that the TRUS diagnostic rate could reach a high level of 94.5% in their study of 54 patients. 4 However, TRUS is an operator-dependent examination, and the false positive rate is as high as 50% as reported in one study. 5 Li et al. also concluded that TRUS is likely inaccurate in the etiological diagnosis of hemospermia based on their retrospective study of 102 patients who also went through a MRI survey. 6 Endorectal coil MRI is considered as an alternative means to detect hemospermia when the result of TRUS is inconclusive. Because of its multiplanar images and eminent soft tissue contrast of the prostate gland and seminal ductal system, MRI could provide more information than TRUS on pelvic anatomical structures without operator variations.
Both TRUS and MRI are relatively non-invasive techniques. This advantage, however, restricts their values mainly to the diagnosis, but not to therapy. In contrast, TUSV is more useful in differential diagnosis, as well as in the prompt treatment.
Yang et al. reported that transurethral endoscopy was very informative for examining the interior of seminal vesicles. 7 Since then, a number of reports have shown that TUSV is a safe and feasible diagnostic tool for hemospermia. [8] [9] [10] [11] [12] [13] Xing et al. reported a 92.3% success rate (98/106 patients) with the ureteroscope introduced into the seminal vesicles. 3 Liu et al. also reported a similar success rate (93.0%) in their TUSV procedures in a prospective observational study based on 114 patients with intractable seminal vesiculitis. 12 In the present study, the success rate of TUSV was 92.1%, which is comparable with similar studies reported in the literature.
Although we have shown two approach methods of TUSV, these methods were used differently in our patient group. In 36 investigative episodes of TUSV, just four were introduced through the ejaculatory duct, whereas most investigations were applying trans-utricle fenestration. The native orifice of the ejaculatory duct is extremely narrow and usually covered with membranous tissue, which makes it very difficult to be visualized even under low-pressure saline irrigation. In contrast, the trans-utricle approach is relatively straight forward because of the larger utricle opening. We advise that surgeons with limited experience should start with the trans-utricle method at the beginning of the learning curve.
Some methods might be helpful for identifying the seminal tract. Colpi et al. reported their approach of trans-scrotal cannulation of the vas deferens and then injecting methyl blue into the vas deferens for the diagnosis of male infertility. 14 Manohar et al. reported their hybrid approach with the combination of transrectal ultrasound and a fluroscope. 15 They transrectally injected a mixture of contrast medium and methyl blue into the seminal vesicles as guided by sonography. After confirming the position of the injection under the fluroscope, they then investigated the verumontanum with a cystourethroscope to identify the opening of the bilateral ejaculatory duct. The obstructed opening was opened with a hooked electrode under the aid of a nephroscope. Wang et al. reported one patient who had received transurethral resection of the ejaculatory ducts to identify the opening. 16 Considering that the above invasive approaches might result in higher surgical risks than the TUSV, we chose not to carry out these technical approaches in our patients. We preferred to carry out MRI for the differential diagnosis of hemospermia if TUSV failed.
Among the 34 episodes with complete remission, half of the investigative episodes showed negative findings. The mechanisms of complete remission in negative structural anomalies remain unclear. One hypothesis is that membranous tissues overlying the opening of the ejaculatory duct might compromise drainage from the seminal tract. 12 The stasis of seminal vesical fluid might subsequently lead to calculi formation and seminal vesiculitis, both of which are refractory to medical treatments. The valve-like membrane could be destroyed and the opening of the seminal tract could be enlarged after TUSV. Therefore, TUSV could provide therapeutic benefits including better drainage of the seminal fluid, concomitant removal of seminal calculi and, more importantly, interrupting the vicious cycle between stasis, calculi and seminal vesiculitis.
Bacterial growth in the seminal vesicle fluid was found in eight patients. The pathogens (including Pseudomonas aeruginosa, Klebsiella pneumoniae and Enterococcus faecalis) were common species of bacteria that cause urinary tract infections. These pathogens were all sensitive to ciprofloxacin, whereas five out of seven P. aeruginosa were resistant to gentamycin. The reason why our empiric ciprofloxacin failed initially might be due to the still ongoing vicious cycle. That might be the explanation for why the hemospermia subsided even though gentamycin used for perioperative irrigation had resistance to the pathogen in the seminal vesicle.
In the present study, the recurrence rate was 11.8%. Han et al. reported a recurrence rate of 10% in 70 patients with intractable hemospermia. 9 Wang et al. reported 4.3% recurrence 3 months after TUSV (7/62 patients). 17 Other studies even reported no recurrence at all. 3, 10, 11, 18 These relative low recurrence rates are strong evidence in support of the efficacy of TUSV.
Two of four patients with recurrent hemospermia had received daily aspirin treatment related to their pre-existing hypertension or diabetes-related atherosclerosis. We did not discontinue their aspirin medication for the indication of cardiovascular or neurovascular protection. One patient underwent a repeated TUSV procedure and recurrent utricle stones were found. He achieved complete alleviation after the second procedure. The remaining three patients received antibiotic treatment alone, and all reported the disappearance of hemospermia after 2 weeks of ciprofloxacin treatment. One possible explanation for the hemospermia becoming less intractable after TUSV is the improved drainage and the broken vicious cycle of hemospermia.
The diagnostic rate of seminal tract stones varies across studies. Han et al. reported the presence of calculi in the seminal vesicles and ejaculatory ducts in 21.4% of patients, 9 and in the report by Liu et al., the calculi rate was 33.3%. 10 Wu et al. found the presence of calculi in the seminal vesicles and verumontanum lumen in 26.9% of their 67 patients. 19 Xing et al. found the presence of calculi in 47.4% of their 114 patients. 3 TUSV confirmed the presence of seminal tract stones in 47 (87%) of their patients, whereas TRUS allowed the same diagnosis of just 59.3% of them. These investigators therefore concluded that the TUSV had a higher overall diagnostic yield than TRUS (74.5 vs 45.3%, P < 0.001).
In the present study, we only compared the diagnostic rates of utricle stones between the two diagnostic tools because of there being few cases with stones in the seminal vesicles or cysts in any locations. For utricle calculi, TUSV resulted in a slightly higher diagnostic rate than TRUS (36.1% vs 27.8%), but the difference was not statistically significant (P = 0.38), likely related to the small sample size. One interesting finding is that a greater proportion of utricle stones was found in our patients, whereas most related studies reported the locations of seminal tract stones mainly in the seminal vesicles. A possible mechanism of the hemospermia during ejaculation is the result of forceful contractions and friction between utricle stones and the whole seminal tract.
Complications of TUSV include perineal pain, retrograde ejaculation, epididymitis, prolonged hematuria, rectal injury and urinary incontinence. Two of our 38 (5.26%) patients developed postoperative epidydimitis without any other complications. Wu et al. reported a 3.95% incidence of postoperative epididymitis in their study of 67 patients. 19 Xing et al.
in their study reported 21.7% postoperative perineal pain, which all subsided within 3 months. 3 Most previous studies reported few, if not the absence of, complications. 9, 10 These studies hence all provided strong evidence on the safety of the procedure.
TUSV could also be applied in other clinical scenarios, including managing seminal tract obstruction for male infertility, prostate or rectal cancer staging to exclude the possibility of seminal vesical invasion, removal of seminal vesical stones and drainage of seminal fluid in patients with refractory seminal vesiculitis. TUSV is therefore a valuable endoscopic procedure with the benefit of concurrent diagnostic and therapeutic management. Some limitations exist in the present study. First, its retrospective design and small sample size. The median follow-up periods did not extend beyond 2 years. Further prospective studies with more patients and longer follow-up periods would provide more powerful evidence in support of the potentials of TUSV as both a diagnostic and a therapeutic tool.
Second, we did not have enough lithiasis fragments in the seminal tract for stone analysis. Both utricle and seminal vesical stones are typically small in size. Most seminal tract stones in the present study were tiny and sand-like in appearance. Under saline irrigation, it was technically challenging to collect enough stones for chemical analysis. Just two of the 16 patients with stones found during TUSV reached the successful stage of stone analysis.
Third, the seminal vesicle fluid collected during the operation for bacterial culture might not come directly from the real seminal tract. Contamination from the urethra or the endoscope could not be wholly excluded. This factor could lead to overestimation of the infectious incidence.
Finally, hemospermia is usually self-limiting, and might spontaneously improve without aggressive treatment. Furuya et al. reported the natural history of hemospermia, and the rates of persistent hemospermia were 34.2% at 3 months, 23.3% at 6 months, 12.5% at 1 year and 7.6% at 2 years. 20 This natural course might be an interfering factor when analyzing the excellent remission rate after TUSV.
In conclusion, TUSV appeared to block the vicious cycle among stasis, calculi and seminal vesiculitis. Therefore, intractable hemospermia could be cured from diagnostic TUSV, even in the case of negative findings. However, TUSV is a challenging procedure with a steep learning curve. Familiarity of the seminal tract anatomy and enough practice of the procedure would improve the surgical success. 
